Literature DB >> 19137798

Predicting postoperative renal failure requiring dialysis, and an analysis of long-term outcome in patients undergoing valve surgery.

Parwis B Rahmanian1, Farzan Filsoufi, Javier G Castillo, Bledi Zaku, Joanna Chikwe, Alain Carpentier, David H Adams.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Previous studies have been unable to identify independent valve-related risk factors for the occurrence of renal failure requiring dialysis (RF-D) in patients undergoing valve surgery. The study aim was to determine the incidence and predictors of renal failure in these patients, and to create a model based on these risk factors that could serve as a tool to predict this complication.
METHODS: Between January 1998 and December 2006, a total of 2,690 consecutive patients (1,546 males, 1,144 females; mean age 64 +/- 15 years) underwent valve or combined valve/coronary artery bypass graft (CABG) surgery at the authors' institution. The main outcome investigated was postoperative RF-D; other postoperative parameters investigated included hospital mortality, major morbidity, length of hospital stay, discharge condition and late survival.
RESULTS: RF-D occurred in 70 patients (2.6%). Multivariate analysis revealed preoperative renal failure (creatinine >2.5 mg/dl) (OR = 4.3), endocarditis (OR = 3.0), congestive heart failure (OR = 2.4), reoperation (OR = 2.3), diabetes (OR = 3.1) and cardiopulmonary bypass time >180 min (OR = 1.7) as independent predictors for postoperative RF-D. Hospital mortality among patients with RF-D was 50% (n = 35) compared to a mortality rate of 3.2% (n = 87) in patients without this complication (p <0.001). The long-term survival of discharged patients with RF-D was significantly decreased compared to those without RF-D. A logistic equation which included the coefficients of the regression analysis was generated to calculate an individual patient's risk for the development of renal failure. The predictive accuracy of the model and validation was measured (ROC area under the curve = 0.750).
CONCLUSION: Renal failure requiring dialysis is a well-known complication, particularly in patients undergoing complex valve operations, such as surgery for endocarditis and double-valve procedures. The poor long-term survival of patients with RF-D underlines the need to direct more resources towards the prevention and treatment of this complication in valve surgery patients.

Entities:  

Mesh:

Year:  2008        PMID: 19137798

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  5 in total

1.  Determinants of acute kidney injury duration after cardiac surgery: an externally validated tool.

Authors:  Jeremiah R Brown; Robert S Kramer; Todd A MacKenzie; Steven G Coca; Kyaw Sint; Chirag R Parikh
Journal:  Ann Thorac Surg       Date:  2011-12-28       Impact factor: 4.330

Review 2.  Sex and the Risk of AKI Following Cardio-thoracic Surgery: A Meta-Analysis.

Authors:  Joel Neugarten; Sandipani Sandilya; Beenu Singh; Ladan Golestaneh
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-20       Impact factor: 8.237

Review 3.  Predicting acute kidney injury after cardiac surgery: a systematic review.

Authors:  Sarah C Huen; Chirag R Parikh
Journal:  Ann Thorac Surg       Date:  2012-01       Impact factor: 4.330

4.  Impact of preoperative elevated serum creatinine on long-term outcome of patients undergoing aortic repair with Stanford A dissection: a retrospective matched pair analysis.

Authors:  Kaveh Eghbalzadeh; Anton Sabashnikov; Carolyn Weber; Mohamed Zeriouh; Ilija Djordjevic; Julia Merkle; Olga Shostak; Sergey Saenko; Payman Majd; Oliver Liakopoulos; Parwis B Rahmanian; Navid Madershahian; Yeong-Hoon Choi; Ferdinand Kuhn-Régnier; Jens Wippermann; Thorsten Wahlers
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-09-19

Review 5.  Acute Kidney Injury following Cardiopulmonary Bypass: A Challenging Picture.

Authors:  Dianxiao Liu; Baohui Liu; Zhenxing Liang; Zhi Yang; Fangjian Ma; Yang Yang; Wei Hu
Journal:  Oxid Med Cell Longev       Date:  2021-03-09       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.